EUROPEAN OPPORTUNITIES TRUST PLC
Legal Entity Identifier: 549300XN7RXQWHN18849
Month end portfolio information as at 30 April 2026
Total Net Assets: £ 435,744,510
Total Assets (including drawdown bank debt): £ 475,744,510
Top Twenty Holdings
|
Stock |
Sector |
Country of Listing |
% of Total Assets (Incl Drawn down bank debt) |
|
Infineon Technologies |
Information Technology |
Germany |
8.2 |
|
Genus Plc |
Health Care |
United Kingdom |
7.9 |
|
Deutsche Boerse |
Financials |
Germany |
6.4 |
|
Experian Plc |
Industrials |
Ireland |
6.4 |
|
Camurus |
Health Care |
Sweden |
6.3 |
|
Novo Nordisk A/S-B |
Health Care |
Denmark |
6.1 |
|
ICG Plc |
Financials |
United Kingdom |
5.6 |
|
Relx Plc |
Industrials |
Netherlands |
5.5 |
|
Dassault Systemes |
Information Technology |
France |
5.3 |
|
Gaztransport Et Technigaz |
Energy |
France |
5.1 |
|
Edenred |
Financials |
France |
3.9 |
|
BioMérieux |
Health Care |
France |
3.7 |
|
Grifols |
Health Care |
Spain |
4.3 |
|
Bae Systems Plc |
Industrials |
United Kingdom |
2.9 |
|
Prysmian |
Industrials |
Italy |
2.8 |
|
Wise Plc |
Financials |
United Kingdom |
2.6 |
|
Ryanair Holdings ADRs |
Industrials |
Ireland |
2.6 |
|
VAT Group |
Industrials |
Switzerland |
2.5 |
|
Thales |
Industrials |
France |
2.1 |
|
Safran |
Industrials |
France |
1.7 |
Country of listing of investee companies
|
Country |
% of Total assets (including drawn down bank debt) |
|
France |
23.2 |
|
United Kingdom |
19.1 |
|
Germany |
16.1 |
|
Ireland |
8.9 |
|
Sweden |
7.2 |
|
Denmark |
6.8 |
|
Netherlands |
5.2 |
|
Spain |
4.3 |
|
Switzerland |
3.6 |
|
Italy |
3.2 |
|
Cash/(Gearing) |
2.4 |
Market Capitalisation of investee companies
|
Market Cap |
% of Total Assets (including Drawn down bank debt) |
|
Large |
76.5 |
|
Mid |
20.8 |
|
Small |
0.3 |
|
Cash/(Gearing) |
2.4 |
The Company's most recent report and accounts and further information for shareholders is published on the Company's website at www.europeanopportunitiestrust.com
Enquiries:
Devon Equity Management Limited,
Richard Pavry
020 3985 0441
05 May 2026